Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.8 AUD | +2.86% | +2.86% | -6.49% |
Mar. 19 | Cyclopharm's Technegas Device Carries Out Imaging of First US Patients | MT |
Mar. 18 | Cyclopharm Limited(ASX:CYC) added to S&P/ASX All Ordinaries Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.49% | 111M | |
+8.75% | 218B | |
+7.66% | 183B | |
+13.34% | 134B | |
+24.69% | 106B | |
-1.44% | 61.12B | |
+4.81% | 50.89B | |
+0.03% | 40.3B | |
+3.13% | 35.53B | |
+27.40% | 32.05B |
- Stock Market
- Equities
- CYC Stock
- News Cyclopharm Limited
- Cyclopharm Advances Rollout of Imaging Drug in the US